U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
109281
Substance Class
Concept
Record UNII
JGA39ICE2V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MUROMONAB-CD3
INN   JAN   MART.   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
OKT3
Code English
MUROMONAB-CD3 [INN]
Common Name English
MUROMONAB CD3 [MI]
Common Name English
ORTHOCLONE OKT3
Brand Name English
PURIFIED IGG2A IMMUNOGLOBULIN MANUFACTURED INVOLVING FUSION OF MOUSE MYELOMA CELLS TO LYMPHOCYTES FROM IMMUNIZED ANIMALS TO PRODUCE A HYBRIDOMA WHICH SECRETES ANTIGEN-SPECIFIC ANTIBODIES TO THE T3 ANTIGEN OF HUMAN T-LYMPHOCYTES
Common Name English
MUROMONAB-CD3 [JAN]
Common Name English
MUROMONAB
Common Name English
OKT-3
Code English
L04AA02
Code English
MUROMOMAB
Common Name English
MUROMONAB-CD3 [USAN]
Common Name English
ANTICD3
Common Name English
MUROMONAB-CD3 [MART.]
Common Name English
MUROMONAB-CD3 [VANDF]
Common Name English
MUROMONAB-CD3 [WHO-DD]
Common Name English
MUROMONAB CD3
MI  
Common Name English
MACS GMP CD3 PURE
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
NDF-RT N0000175620
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
WHO-VATC QL04AA02
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
WHO-ATC L04AA02
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
LIVERTOX 655
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
NDF-RT N0000175550
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
NCI_THESAURUS C574
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
NDF-RT N0000175617
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
NDF-RT N0000175619
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
Code System Code Type Description
NCI_THESAURUS
C1321
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
DRUG CENTRAL
5177
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
RXCUI
42405
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY RxNorm
IUPHAR
6889
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
INN
6281
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
EVMPD
SUB129673
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
ALTERNATIVE
WIKIPEDIA
MUROMONAB-CD3
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
CAS
140608-64-6
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
MESH
D016853
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
DRUG BANK
DB00075
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
EVMPD
SUB03355MIG
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
FDA UNII
JGA39ICE2V
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
ChEMBL
CHEMBL1201608
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
MERCK INDEX
M7663
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY Merck Index
EPA CompTox
140608-64-6
Created by admin on Sat Jun 26 18:56:41 UTC 2021 , Edited by admin on Sat Jun 26 18:56:41 UTC 2021
PRIMARY
This is a non-substance concept
Related Record Type Details
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
CD3
CD3
TARGET -> INHIBITOR
Related Record Type Details
MUROMONAB-CD3
ACTIVE MOIETY
This is a non-substance concept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966